SBIR/STTR Research Award

Intraoperative Pulsed Field Ablation and Lesion Assessment System

Award identifier bb0a8b73deef5f13b362bd7c6735f71d2a2ea7104eb9c1c7505ab9b43525243bAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$293,880

Program and phase

SBIR · Phase I

Award year

2023

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
SIGT LLC
Proposal award date
2023-09-01
Contract end date
2024-08-31
UEI
TDS1HMV3LM26
Solicitation number
PA22-176
Topic code
NHLBI

Research abstract

Over 6 million Americans suffer from atrial fibrillation (AF), which negatively impacts their quality of life and is associated with high morbidity and mortality. Pulsed Electric Field Ablation (PFA) has emerged as a promising; non-thermal, tissue-specific ablation modality for treatment of AF. During PFA, trains of ultrashort (µs duration) high voltage (~2KV) electric pulses are delivered to the myocardium via single or multi-electrode catheters resulting in lesion formation by induced electric fields (e-fields).Intraoperatively, efficacy of PFA is assessed by diminution of local electrograms (iEGMs), which is unreliable and can be confounded by myocardial stunning and edema formation. Currently, there are no methods to intraoperatively assess PFA procedures, assess and confirm durable lesion formation.An intraoperative PFA-LAS, which can assess procedure parameters, assess and confirm durable lesion formation, will enable effectively deliver contiguous durable transmural lesions; significantly improving the safety and efficacy of PFA procedures.During this Phase 1 SBIR Project, we propose to develop a novel intraoperative Cardiac PFA Lesion Assessment System (PFA-LAS) using “High Frequency Dielectric Sensing” (HFDS) technology developed in our lab. HFDS technology involves redesigning the ablation electrodes of the PFA catheter as “miniature antennae”; and intraoperatively measuring their High Frequency Reflection Impedance Electrical Properties (HFEPs) at MHz-GHz frequencies. This enables simultaneously assess dielectric properties of the volume of tissue undergoing ablation in contact with electrode, and deliver the high voltage PFA pulses with the same electrodes; hence intraoperatively assess procedure parameters and confirm durable lesion formation. The system fits in an interventional EP lab, with no changes to procedural workflow.We will design, prototype and test in bench and animals, a first generation PFA-LAS, and definitively demonstrate its feasibility to intraoperatively monitor procedure parameters, assess and confirm durable lesion formation.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

3 SBIR/STTR records share this UEI (2019–2023). Reported award amounts total $2,172,321. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.